HIV/AIDS research in India: Past, present and future

Current Science

Volumn 98, Issue 3, 2010, Pages 335-345

  Ranga, Udaykumar ^a   Banerjea, Akhil ^b   Chakrabarti, Sekhar ^c   Mitra, Debashis ^d  

^a JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^d NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

HIV AIDS; Seroconverters; Viral infection; Viral molecular epidemiology

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77953340928     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (154)

1. Simoes, E. A., Babu, P. G., John, T. J., Nirmala, S., Solomon, S., Lakshminarayana, C. S. and Quinn, T. C., Evidence for HTLVIII infection in prostitutes in Tamil Nadu (India). Indian J. Med. Res., 1987, 85, 335-338.
2. Weniger, B. G., Takebe, Y., Ou, C. Y. and Yamazaki, S., The molecular epidemiology of HIV in Asia. AIDS, 1994, 8, S13-S28.
3. Jain, M. K., John, T. J. and Keusch, G. T., A review of human immunodeficiency virus infection in India. J. Acquir. Immune Defic. Syndr., 1994, 7, 1185-1194.
4. Bollinger, R. C., Tripathy, S. P. and Quinn, T. C., The human immunodeficiency virus epidemic in India. Current magnitude and future projections. Medicine (Baltimore), 1995, 74, 97-106.
5. Solomon, S. and Ganesh, A. K., HIV in India. Top. HIV Med., 2003, 10, 19-24.
6. Shankar, S. K. et al., Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J. Med. Res., 2005, 121, 468-488.
7. Kandathil, A. J., Ramalingam, S., Kannangai, R., David, S. and Sridharan, G., Molecular epidemiology of HIV. Indian J. Med. Res., 2005, 121, 333-344.
8. Steinbrook, R., HIV in India -the challenges ahead. New Eng. J. Med., 2007, 356, 1197-1201.
9. Lakhashe, S., Thakar, M., Godbole, S., Tripathy, S. and Paranjape, R., HIV infection in India: epidemiology, molecular epidemiology and pathogenesis. J. Biosci., 2008, 33, 515-525.
10. Singh, H. K. et al., The Indian pediatric HIV epidemic: a systematic review. Curr. HIV Res., 2008, 6, 419-432.
11. Neogi, U. et al., Global HIV-1 molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: functional and pathogenic implications of genetic variation. Indian J. Exp. Biol., 2009, 47, 424-431.
12. Sahni, A. K., Prasad, V. V. and Seth, P., Genomic diversity of human immunodeficiency virus type-1 in India. Int. J. STD AIDS, 2002, 13, 115-118.
13. Mandal, D., Jana, S., Bhattacharya, S. K. and Chakrabarti, S., HIV type 1 subtypes circulating in eastern and northeastern regions of India. AIDS Res. Hum. Retroviruses, 2002, 18, 1219-1227.
14. Kurle, S., Tripathy, S., Jadhav, S., Agnihotri, K. and Paranjape, R., Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India. AIDS Res. Hum. Retroviruses, 2004, 20, 1113-1118.
15. Siddappa, N. B. et al., Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India. AIDS, 2005, 19, 1426-1429.
16. Ahmad, K. M., Mujtaba, S., Das, R., Zafrullah, M., Sehgal, S. and Jameel, S., Nef sequences of primary HIV type 1 isolates from northern India. AIDS Res. Hum. Retroviruses, 1998, 14, 1491-1493.
17. Bano, A. S., Sood, V., Neogi, U., Goel, N., Kuttiat, V. S., Wanchu, A. and Banerjea, A. C., Genetic and functional characterization of HIV-1 VprC variants from North India: presence of unique recombinants with mosaic genomes from B, C and D subtypes within the ORF of Vpr. J. Gen. Virol., 2009, 90, 2768-2776.
18. Gadkari, D. A., Moore, D., Sheppard, H. W., Kulkarni, S. S., Mehendale, S. M. and Bollinger, R. C., Transmission of genetically diverse strains of HIV-1 in Pune, India. Indian J. Med. Res., 1998, 107, 1-9.
19. Kumar, M., Jain, S. K., Pasha, S. T., Chattopadhaya, D., Lal, S. and Rai, A., Genomic diversity in the regulatory nef gene sequences in Indian isolates of HIV type 1: emergence of a distinct subclade and predicted implications. AIDS Res. Hum. Retroviruses, 2006, 22, 1206-1219.
20. Siddappa, N. B. et al., Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. J. Clin. Microbiol., 2004, 42, 2742-2751.
21. Ramalingam, S. et al., Subtype and cytokine profiles of HIV infected individuals from south India. Indian J. Med. Res., 2005, 121, 226-234.
22. Dietrich, U. et al., HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate. AIDS, 1993, 7, 23-27.
23. Shankarappa, R. et al., Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J. Virol., 2001, 75, 10479-10487.
24. Siddappa, N. B. et al., Gene expression analysis from Human Immunodeficiency Virus type-1 subtype C promoter and construction of bicistronic reporter vectors. AIDS Res. Hum. Retroviruses, 2007, 23, 1268-1278.
25. Mehendale, S. M. et al., Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India. J. Infect. Dis., 1995, 172, 1486-1491.
26. Solomon, S., Kumarasamy, N., Ganesh, A. K. and Amalraj, R. E., Prevalence and risk factors of HIV-1 and HIV-2 infection in urban and rural areas in Tamil Nadu, India. Int. J. STD AIDS, 1998, 9, 98-103.
27. Chakrabarti, S. et al., HIV-1 subtypes in injecting drug users and their non-injecting wives in Manipur, India. Indian J. Med. Res., 2000, 111, 189-194.
28. Panda, S. et al., Transmission of HIV from injecting drug users to their wives in India. Int. J. STD AIDS, 2000, 11, 468-473.
29. Ramalingam, S., Kannangai, R., Prakash, K. J., Jesudason, M. V. and Sridharan, G., Per-exposure rate of transmission of HIV-1, HIV-1/2, and HIV-2 from women to men may be higher in India. J. Acquir. Immune Defic. Syndr., 2000, 25, 97-98.
30. Mullick, R., Sengupta, S., Sarkar, K., Saha, M. K. and Chakrabarti, S., Phylogenetic analysis of env, gag, and tat genes of HIV type 1 detected among the injecting drug users in West Bengal, India. AIDS Res. Hum. Retroviruses, 2006, 22, 1293-1299.
31. Tsuchie, H., Maniar, J. K., Yoshihara, N., Imai, M., Kurimura, T. and Kitamura, T., Sequence analysis of V3 loop region of HIV-1 strains prevalent in India. Jpn. J. Med. Sci. Biol., 1993, 46, 95-100.
32. Jameel, S., Zafrulla, M., Ahmad, M., Kapoor, G. P. and Sehgal, S., A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants. AIDS, 1995, 9, 685-690.
33. Cassol, S. et al., Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology. AIDS Res. Hum. Retroviruses, 1996, 12, 1435-1441.
34. Tripathy, S. et al., Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India. AIDS Res. Hum. Retroviruses, 1996, 12, 1203-1206.
35. Tripathy, S. P. et al., Subtype B and subtype C HIV type 1 recombinants in the Northeastern State of Manipur, India. AIDS Res. Hum. Retroviruses, 2005, 21, 152-157.
36. Rodriguez, M. A., Shen, C., Ratner, D., Paranjape, R. S., Kulkarni, S. S., Chatterjee, R. and Gupta, P., Genetic and functional characterization of the LTR of HIV-1 subtypes A and C circulating in India. AIDS Res. Hum. Retroviruses, 2007, 23, 1428-1433.
37. Deshpande, A., Jauvin, V., Pinson, P., Jeannot, A. C. and Fleury, H. J., Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008. AIDS Res. Hum. Retroviruses, 2009, 25, 633-635.
38. Rubsamen-Waigmann, H., Briesen, H. V., Maniar, J. K., Rao, P. K., Scholz, C. and Pfutzner, A., Spread of HIV-2 in India. Lancet, 1991, 337, 550-551.
39. Pfutzner, A., Dietrich, U., von Eichel, U., von Briesen, H., Brede, H. D., Maniar, J. K. and Rubsamen-Waigmann, H., HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. J. Acquir. Immune Defic. Syndr., 1992, 5, 972-977.
40. Babu, P. G., Saraswathi, N. K., Devapriya, F. and John, T. J., The detection of HIV-2 infection in southern India. Indian J. Med. Res., 1993, 97, 49-52.
41. Saran, R. and Gupta, A. K., HIV-2 and HIV-1/2 seropositivity in Bihar. Indian J. Public Health, 1995, 39, 119-120.
42. Kulshreshtha, R., Mathur, A., Chattopadhya, D. and Chaturvedi, U. C., HIV-2 prevalence in Uttar Pradesh. Indian J. Med. Res., 1996, 103, 131-133.
43. Kamat, H. A., Banker, D. D. and Koppikar, G. V., Increasing prevalence of dual HIV-1-2 infections among voluntary blood donors in Mumbai (Bombay). Indian J. Med. Sci., 1998, 52, 548-552.
44. Lakshmi, V., Teja, V. D., Rani, T. S., Subhadha, K., Upadhyaya, A. C. and Shantaram, V., Human immunodeficiency virus infection in a tertiary care hospital -clinical and microbiological profile. J. Assoc. Physicians India, 1998, 46, 363-367.
45. Pal, B. B., Acharya, A. S. and Satyanarayana, K., Seroprevalence of HIV infection among jail inmates in Orissa. Indian J. Med. Res., 1999, 109, 199-201.
46. Grez, M. et al., Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J. Virol., 1994, 68, 2161-2168.
47. Kulkarni, S. S., Tripathy, S., Paranjape, R. S., Mani, N. S., Joshi, D. R., Patil, U. and Gadkari, D. A., Isolation and preliminary characterization of two HIV-2 strains from Pune, India. Indian J. Med. Res., 1999, 109, 123-130.
48. Kannangai, R. et al., Molecular confirmation of human immunodeficiency virus (HIV) type 2 in HIV-seropositive subjects in south India. Clin. Diagn. Lab. Immunol., 2000, 7, 987-989.
49. Kannangai, R. et al., HIV-2 subtype circulating in India (South). J. Acquir. Immune. Defic. Syndr., 2003, 33, 219-222.
50. Bhanja, P., Mandal, D. K., Jana, S., Bhattacharya, S. K. and Chakrabarti, S., Detection and characterization of HIV type 2 in Calcutta, India. AIDS Res. Hum. Retroviruses, 2004, 20, 101-104.
51. Kulkarni, S. et al., Indian primary HIV-2 isolates and relationship between V3 genotype, biological phenotype and coreceptor usage. Virology, 2005, 337, 68-75.
52. Tamhane, M., Mukhopadhyaya, R. and Mukhopadhyaya, R., Characterization of a long terminal repeat region from an infectious Indian HIV type 2 isolate. AIDS Res. Hum. Retroviruses, 2005, 21, 592-596.
53. Gurjar, R. S., Ravi, V. and Desai, A., Molecular epidemiology of HIV type 2 infections in South India. AIDS Res. Hum. Retroviruses, 2009, 25, 363-372.
54. Jadhav, S., Tripathy, S., Kulkarni, S., Agnihotri, K., Risbud, A. and Paranjape, R., Molecular phylogenetics of nearly full-length HIV type 2 envelope gene sequences from West India. AIDS Res. Hum. Retroviruses, 2009, 25, 115-121.
55. Santhosh, C. V., Tamhane, M. C., Mukhopadhyaya, R. and Mukhopadhyaya, R., Full-length genome characterization of an HIV Type 2 isolate from India. AIDS Res. Hum. Retroviruses, 2008, 24, 1-3.
56. Gurjar, S. R., Mangaiarkarasi, A., Ravi, V., Ranga, U. and Desai, A., Molecular characterization of a full-length genome of a HIV-2 isolate from India. J. Acquir. Immune. Defic. Syndr., 2009, 52, 329-335.
57. Rao, A. S. R. S., Thomas, K., Sudhakar, K. and Maini, P. K., HIV/AIDS epidemic in India and predicting the impact of the national response: mathematical modeling and analysis. Mathematical Biosci. Eng., 2009, 6, 781-815.
58. Misra, S. N., Sengupta, D. and Satpathy, S. K., AIDS in India: recent trends in opportunistic infections. Southeast. Asian J. Trop. Med. Public Health, 1998, 29, 373-376.
59. Kumarasamy, N., Solomon, S., Flanigan, T. P., Hemalatha, R., Thyagarajan, S. P. and Mayer, K. H., Natural history of human immunodeficiency virus disease in southern India. Clin. Infect. Dis., 2003, 36, 79-85.
60. Vajpayee, M., Kanswal, S., Seth, P. and Wig, N., Spectrum of opportunistic infections and profile of CD4+ counts among AIDS patients in North India. Infection, 2003, 31, 336-340.
61. Sharma, S. K., Kadhiravan, T., Banga, A., Goyal, T., Bhatia, I. and Saha, P. K., Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India. BMC Infect. Dis., 2004, 4, 52.
62. Kumarasamy, N., Vallabhaneni, S., Flanigan, T. P., Mayer, K. H. and Solomon, S., Clinical profile of HIV in India. Indian J. Med. Res., 2005, 121, 377-394.
63. Santosh, V. et al., Pathological lesions in HIV positive patients. Indian J. Med. Res., 1995, 101, 134-141.
64. Mahadevan, A. et al., Characterization of human immunodeficiency virus (HIV)-infected cells in infiltrates associated with CNS opportunistic infections in patients with HIV Clade C infection. J. Neuropathol. Exp. Neurol., 2007, 66, 799-808.
65. Bentwich, Z., Kalinkovich, A. and Weisman, Z., Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today, 1995, 16, 187-191.
66. Hazenberg, M. D. et al., Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS, 2003, 17, 1881-1888.
67. Lawn, S. D., AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J. Infect., 2004, 48, 1-12.
68. Morgan, D. and Whitworth, J., The natural history of HIV-1 infection in Africa. Nat. Med., 2001, 7, 143-145.
69. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults, 1992
70. Mellors, J. W. et al., Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med., 1997, 126, 946-954.
71. Rodriguez, B. et al., Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA, 2006, 296, 1498-1506.
72. Brumme, Z. et al., Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa. Clin. Infect. Dis., 2009, 49, 956-964.
73. Anglaret, X. et al., CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 1997, 14, 361-367.
74. Kassu, A. et al., Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin. Diagn. Lab Immunol., 2001, 8, 1171-1176.
75. Bussmann, H. et al., Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clin. Diagn. Lab Immunol., 2004, 11, 930-935.
76. Kam, K. M., Leung, W. L., Kwok, M. Y., Hung, M. Y., Lee, S. S. and Mak, W. P., Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults. Clin. Diagn. Lab Immunol., 1996, 3, 326-330.
77. Jiang, W. et al., Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai. Clin. Diagn. Lab Immunol., 2004, 11, 811-813.
78. Ramalingam, S., Kannangai, R., Zachariah, A., Mathai, D. and Abraham, C., CD4 counts of normal and HIV-infected south Indian adults: do we need a new staging system? Natl. Med. J. India, 2001, 14, 335-339.
79. Vajpayee, M., Kanswal, S., Wig, N. and Seth, P., Evaluation of CD4 counts and percentages in the HIV infected Indian population. Southeast Asian J. Trop. Med. Public Health, 2004, 35, 144-146.
80. Attili, V. S., Sundar, S., Singh, V. P. and Rai, M., Validity of existing CD4+ classification in north Indians, in predicting immune status. J. Infect., 2005, 51, 41-46.
81. Kannangai, R. et al., Evidence for lower CD4+ T cell and higher viral load in asymptomatic HIV-1 infected individuals of India: implications for therapy initiation. Indian J. Med. Microbiol., 2008, 26, 217-221.
82. Saxena, R. K. et al., Normal ranges of some select lymphocyte sub-populations in peripheral blood of normal healthy Indians. Curr. Sci., 2004, 86, 969-975.
83. Reichert, T. et al., Lymphocyte subset reference ranges in adult Caucasians. Clin. Immunol. Immunopathol., 1991, 60, 190-208.
84. Kannangai, R., Prakash, K. J., Ramalingam, S., Abraham, O. C., Mathews, K. P., Jesudason, M. V. and Sridharan, G., Peripheral CD4+/CD8+ T-lymphocyte counts estimated by an immunocapture method in the normal healthy south Indian adults and HIV seropositive individuals. J. Clin. Virol., 2000, 17, 101-108.
85. Nag, V. L., Agarwal, P., Venkatesh, V., Rastogi, P., Tandon, R. and Agrawal, S. K., A pilot study on observations on CD4 and CD8 counts in healthy HIV seronegative individuals. Indian J. Med. Res., 2002, 116, 45-49.
86. Ray, K., Gupta, S. M., Bala, M., Muralidhar, S. and Kumar, J., CD4/CD8 lymphocyte counts in healthy, HIV-positive individuals and AIDS patients. Indian J. Med. Res., 2006, 124, 319-330.
87. Murugavel, K. G. et al., Establishment of T-lymphocyte subset reference intervals in a healthy adult population in Chennai, India. Indian J. Med. Res., 2009, 129, 59-63.
88. Uppal, S. S., Verma, S. and Dhot, P. S., Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity, and smoking. Cytometry, 2003, 52B, 32-36.
89. Mehendale, S. M. et al., Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India. AIDS Res. Hum. Retroviruses, 2002, 18, 1175-1179.
90. Lyles, R. H. et al., Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J. Infect. Dis., 2000, 181, 872-880.
91. Ding, M. et al., Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India. J. Acquir. Immune. Defic. Syndr., 2009, 50, 119-125.
92. Hira, S. K., Shroff, H. J., Lanjewar, D. N., Dholkia, Y. N., Bhatia, V. P. and Dupont, H. L., The natural history of human immunodeficiency virus infection among adults in Mumbai. Natl. Med. J. India, 2003, 16, 126-131.
93. Lemp, G. F. et al., Projections of AIDS morbidity and mortality in San Francisco. JAMA, 1990, 263, 1497-1501.
94. Kumarasamy, N., Solomon, S., Chaguturu, S. K., Cecelia, A. J., Vallabhaneni, S., Flanigan, T. P. and Mayer, K. H., The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin. Infect. Dis., 2005, 41, 1525-1528.
95. Paranjape, R. S., Gadkari, D. A., Lubaki, M., Quinn, T. C. and Bollinger, R. C., Cross-reactive HIV-1-specific CTL in recent seroconverters from Pune, India. Indian J. Med. Res., 1998, 108, 35-41.
96. Thakar, M. R. et al., Consistent subtype-specific anti-HIV Type 1 T lymphocyte responses in Indian subjects recently infected with HIV type 1. AIDS Res. Hum. Retroviruses, 2002, 18, 1389-1393.
97. Kaushik, S., Vajpayee, M., Wig, N. and Seth, P., Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population. Clin. Exp. Immunol., 2005, 142, 388-397.
98. Thakar, M. R. et al., Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. J. Infect. Dis., 2005, 192, 749-759.
99. Mendiratta, S. et al., Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals. Med. Microbiol. Immunol., 2009, 198, 47-56.
100. Srikanth, P., Castillo, R. C., Sridharan, G., John, T. J., Zachariah, A., Mathai, D. and Schwartz, D. H., Increase in plasma IL-10 levels and rapid loss of CD4+ T cells among HIV-infected individuals in south India. Int. J. STD AIDS, 2000, 11, 49-51.
101. Wig, N. et al., Tumor necrosis factor-alpha levels in patients with HIV with wasting in South Asia. AIDS Patient. Care STDS, 2005, 19, 212-215.
102. Wanchu, A., Arora, S., Bhatnagar, A., Sud, A., Bambery, P. and Singh, S., Beta2 microglobulin as a surrogate marker for HIV infection: good correlation with CD4 counts. Indian J. Pathol. Microbiol., 2004, 47, 298-301.
103. Ramalingam, S. et al., Chemokine profile among human immunodeficiency virus-1 (HIV-1) infected individuals from southern India. Indian J. Med. Res., 2008, 127, 133-139.
104. Michael, N. L., Louie, L. G. and Sheppard, H. W., CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet, 1997, 350, 741-742.
105. Husain, S., Goila, R., Shahi, S. and Banerjea, A. C., First report of a healthy Indian heterozygous for delta 32 mutant of HIV-1 co-receptor-CCR5 gene. Gene, 1998, 207, 141-147.
106. Kaur, G. et al., Distribution of CCR2 polymorphism in HIV-1-infected and healthy subjects in North India. Int. J. Immunogenet., 2007, 34, 153-156.
107. Kaur, G. et al., Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians. Hum. Immunol., 2007, 68, 454-461.
108. Hariharan, M., Scaria, V., Pillai, B. and Brahmachari, S. K., Targets for human encoded microRNAs in HIV genes. Biochem. Biophys. Res. Commun., 2005, 337, 1214-1218.
109. Ahluwalia, J. K. et al., Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology, 2008, 5, 117.
110. Kaur, G. and Mehra, N., Genetic determinants of HIV-1 infection and progression to AIDS: susceptibility to HIV infection. Tissue Antigens, 2009, 73, 289-301.
111. Suresh, P., Wanchu, A., Sachdeva, R. K. and Bhatnagar, A., Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India. J. Clin. Immunol., 2006, 26, 476-484.
112. Singh, P., Kaur, G., Sharma, G. and Mehra, N. K., Immunogenetic basis of HIV-1 infection, transmission and disease progression. Vaccine, 2008, 26, 2966-2980.
113. Chaudhry, A. et al., The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J. Immunol., 2005, 175, 4566-4574.
114. Chaudhry, A., Das, S. R., Jameel, S., George, A., Bal, V., Mayor, S. and Rath, S., A two-pronged mechanism for HIV-1 Nefmediated endocytosis of immune costimulatory molecules CD80 and CD86. Cell Host. Microbe, 2007, 1, 37-49.
115. Chaudhry, A. et al., HIV-1 Nef promotes endocytosis of cell surface MHC Class II molecules via a constitutive pathway. J. Immunol., 2009, 183, 2415-2424.
116. Hussain, A., Wesley, C., Khalid, M., Chaudhry, A. and Jameel, S., Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation. J. Virol., 2008, 82, 893-902.
117. Satishchandra, P. et al., Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J. Med. Res., 2000, 111, 14-23.
118. Wadia, R. S., Pujari, S. N., Kothari, S., Udhar, M., Kulkarni, S., Bhagat, S. and Nanivadekar, A., Neurological manifestations of HIV disease. J. Assoc. Physicians India, 2001, 49, 343-348.
119. Kothari, K. and Goyal, S., Clinical profile of AIDS. J. Assoc. Physicians India, 2001, 49, 435-438.
120. Ranga, U. et al., Tat protein of human immunodeficiency virus Type 1 subtype C strains is a defective chemokine. J. Virol., 2004, 78, 2586-2590.
121. Joseph, J. and Prasad, V., NeuroAIDS in the developing world. J. Neurovirol., 2005, 11, 4-6.
122. Mishra, M., Vetrivel, S., Siddappa, N. B., Ranga, U. and Seth, P., Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann. Neurol., 2007, 63, 366-376.
123. Rao, V. R. et al., HIV-1 clade-specific differences in the induction of neuropathogenesis. J. Neurosci., 2008, 28, 10010-10016.
124. Dash, P. K. et al., Exceptional molecular and coreceptorrequirement properties of molecular clones isolated from an human immunodeficiency virus Type-1 subtype-C infection. Retrovirology, 2008, 5, 25.
125. Gupta, S., Boppana, R., Mishra, G. C., Saha, B. and Mitra, D., HIV-1 Tat suppresses gp120-specific T cell response in IL-10-dependent manner. J. Immunol., 2008, 180, 79-88.
126. Gupta, S., Boppana, R., Mishra, G. C., Saha, B. and Mitra, D., Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function. Immunology, 2008, 124, 553-561.
127. Dandekar, D. H., Ganesh, K. N. and Mitra, D., HIV-1 Tat directly binds to NFkappaB enhancer sequence: role in viral and cellular gene expression. Nucleic Acids Res., 2004, 32, 1270-1278.
128. Kumar, M. and Mitra, D., Heat shock protein 40 is necessary for human immunodeficiency virus-1 Nef-mediated enhancement of viral gene expression and replication. J. Biol. Chem., 2005, 280, 40041-40050.
129. Ladha, J. S., Tripathy, M. K. and Mitra, D., Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis. Cell Death Differ., 2005, 12, 1417-1428.
130. Tripathy, M. K. and Mitra, D., Differential modulation of mitochondrial OXPHOS system during HIV-1 induced T-cell apoptosis: up regulation of Complex-IV subunit COX-II and its possible implications. Apoptosis, 2010, 15, 28-40.
131. Rajendra, K. P., Singhal, P. K., Vinod, S. S. and Mahalingam, S., A non-canonical transferable signal mediates nuclear import of simian immunodeficiency virus Vpx protein. J. Mol. Biol., 2003, 331, 1141-1156.
132. Rajendra, K. P., Singhal, P. K., Subba Rao, M. R. and Mahalingam, S., Phosphorylation by MAPK regulates simian immunodeficiency virus Vpx protein nuclear import and virus infectivity. J. Biol. Chem., 2005, 280, 8553-8563.
133. Singhal, P. K., Kumar, P. R., Rao, M. R., Kyasani, M. and Mahalingam, S., Simian immunodeficiency virus Vpx is imported into the nucleus via importin alpha-dependent and -independent pathways. J. Virol., 2006, 80, 526-536.
134. Singhal, P. K., Rajendra, K. P., Subba Rao, M. R. and Mahalingam, S., Nuclear export of simian immunodeficiency virus Vpx protein. J. Virol., 2006, 80, 12271-12282.
135. Rossi, J. J., June, C. H. and Kohn, D. B., Genetic therapies against HIV. Nat. Biotechnol., 2007, 25, 1444-1454.
136. Goila, R. and Banerjea, A. C., Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNAenzyme. FEBS Lett., 1998, 436, 233-238.
137. Santhosh, C. V., Tamhane, M. C., Kamat, R. H., Patel, V. V. and Mukhopadhyaya, R., A lentiviral vector with novel multiple cloning sites: stable transgene expression in vitro and in vivo. Biochem. Biophys. Res. Commun., 2008, 371, 546-550.
138. Talwar, G. P. et al., A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens. Int. J. Antimicrob. Agents, 2008, 32, 180-185.
139. Ahluwalia, A., Gokulan, K., Nath, I. and Rao, D. N., Modification of delivery system enhances MHC nonrestricted immunogenicity of V3 loop region of HIV-1 gp120. Microbiol. Immunol., 1997, 41, 779-784.
140. Gokulan, K. and Rao, D. N., Bioactive fragment of human IL-1beta [163-171] modulates the immune response to synthetic peptides of HIV. Microbiol. Immunol., 1997, 41, 965-974.
141. Gokulan, K., Khare, S. and Rao, D. N., Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40). DNA Cell Biol., 1999, 18, 623-630.
142. Agrawal, L., Haq, W., Hanson, C. V. and Rao, D. N., Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity. J. Immune. Based Ther. Vaccines., 2003, 1, 5.
143. Pun, P. B., Bhat, A. A., Mohan, T., Kulkarni, S., Paranjape, R. and Rao, D. N., Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses. Int. Immunopharmacol., 2009, 9, 468-477.
144. Arora, A. and Seth, P., Immunization with HIV-1 subtype B gp160-DNA induces specific as well as cross reactive immune responses in mice. Indian J. Med. Res., 2001, 114, 1-9.
145. Kumar, S. and Seth, P., Immunogenicity of recombinant Modified Vaccinia Ankara viruses (rMVA) expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice. Viral Immunol., 2004, 17, 574-579.
146. Kumar, S., Aggarwal, P., Vajpayee, M., Pandey, R. M. and Seth, P., Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India. Vaccine, 2006, 24, 2585-2593.
147. Varadarajan, R. et al., Characterization of gp120 and its singlechain derivatives, gp120-CD4D12 and gp120-M9: implications for targeting the CD4i epitope in human immunodeficiency virus vaccine design. J. Virol., 2005, 79, 1713-1723.
148. Chakraborty, K. et al., Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies. Biochem. J., 2006, 399, 483-491.
149. Ramakrishna, L., Anand, K. K., Mohankumar, K. M. and Ranga, U., Codon optimization of the Tat antigen of human immunodeficiency virus Type 1 generates strong immune responses in mice following genetic immunization. J. Virol., 2004, 78, 9174-9189.
150. Ramakrishna, L., Anand, K. K., Mahalingam, M., Mohankumar, K. M., Ramani, S., Siddappa, N. B. and Ranga, U., Codon optimization and ubiquitin conjugation of human immunodeficiency virus-1 Tat lead to enhanced cell-mediated immune responses. Vaccine, 2004, 22, 2586-2598.
151. Kashi, V. P. et al., HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently. Vaccine, 2009, 27, 6739-6747.
152. Lakhashe, S. K., Kulkarni, S. S., Thakar, M. R., Ghate, M. V. and Paranjape, R. S., Extensive cross-reactive neutralizing antibody response in Indian patients with limited genetic diversity of HIV-1. Virology, 2007, 359, 295-301.
153. Kulkarni, S. et al., Neutralizing antibody responses in recent seroconverters with HIV-1 subtype C infections in India. AIDS Res. Hum. Retroviruses, 2008, 24, 1159-1166.
154. Mehendale, S. et al., A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV Type 1 subtype C adenoassociated virus vaccine. AIDS Res. Hum. Retroviruses, 2008, 24, 873-880.